Detalhe da pesquisa
1.
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial.
Int J Cancer
; 153(6): 1241-1250, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294085
2.
Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study.
Lancet Oncol
; 23(6): 768-780, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35489363
3.
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study.
Lancet Oncol
; 22(9): 1312-1321, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416158
4.
Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationale.
Future Oncol
; 15(9): 929-941, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30689402
5.
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
J Clin Oncol
; 42(11): 1222-1228, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38227898
6.
Sarcoidosis and Sjögren's syndrome: clinical and salivary evaluation.
J Oral Pathol Med
; 42(8): 594-9, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23480241
7.
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.
Front Oncol
; 13: 1223282, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37664025
8.
Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.
Front Oncol
; 13: 1343027, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38495081
9.
An Open-Label Phase 1 Study to Determine the Effect of Lenvatinib on the Pharmacokinetics of Midazolam, a CYP3A4 Substrate, in Patients with Advanced Solid Tumors.
Eur J Drug Metab Pharmacokinet
; 45(3): 373-383, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32067158
10.
Analysis of digenic epistatic effects and QE interaction effects QTL controlling grain weight in rice.
J Zhejiang Univ Sci
; 5(4): 371-7, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-14994424
11.
Oxalic acid biosynthesis is encoded by an operon in Burkholderia glumae.
FEMS Microbiol Lett
; 304(2): 177-82, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20141533
12.
The chloroplast protease subunit ClpP4 is a substrate of the E3 ligase AtCHIP and plays an important role in chloroplast function.
Plant J
; 49(2): 228-37, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17241447
13.
AtCHIP functions as an E3 ubiquitin ligase of protein phosphatase 2A subunits and alters plant response to abscisic acid treatment.
Plant J
; 46(4): 649-57, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16640601
14.
Expression of an Arabidopsis vacuolar sodium/proton antiporter gene in cotton improves photosynthetic performance under salt conditions and increases fiber yield in the field.
Plant Cell Physiol
; 46(11): 1848-54, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16179357
15.
Overexpression of the Arabidopsis 14-3-3 protein GF14 lambda in cotton leads to a "stay-green" phenotype and improves stress tolerance under moderate drought conditions.
Plant Cell Physiol
; 45(8): 1007-14, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15356326